Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Natera, Inc. NTRA

Healthcare  —  Diagnostics & Research
412.56 3.77 0.92% as of 25 Sep
Market cap
$59.2B
P/E
0.0×
Cash Flow Champion (3y)
Growth Flags show if company had growth for consecutive years
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K
Quarterly (Descending) Quarterly (Ascending) Annual (Descending) Annual (Ascending) TTM (Descending) TTM (Ascending)
Download Excel — free account
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio 13.58 11.63 6.58 4.62 13.52 20.62 7.75 3.13 2.41 2.89
P/FCF ratio 287.05 285.13 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF 423.90 373.30 (123.61) (46.69) (85.65) (109.99) (155.66) (63.03) (17.95) (20.69)
P/B ratio 18.29 16.52 9.30 5.37 12.95 16.58 8.41 25.11 19.86 5.76
Price to Tangible BV 26.15 16.67 9.30 5.37 12.95 16.58 8.41 25.11 19.86 5.76
EV/Sales 13.27 11.28 6.10 3.96 12.59 19.38 6.70 3.00 2.43 2.53
EV/EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF 142.18 141.09 (26.75) (7.53) (23.49) (41.52) (31.93) (10.95) (5.20) (7.25)
EV/FCF 280.55 276.45 (23.08) (6.78) (20.92) (37.49) (29.62) (10.38) (4.73) (5.52)
Quick Ratio 3.11 3.73 3.77 3.68 4.73 4.10 2.75 1.94 1.54 1.67
Current Ratio 3.39 4.00 4.10 3.90 4.99 4.33 2.91 2.11 1.71 1.81
Net Debt/EBITDA 3.74 4.65 1.23 1.04 1.30 2.40 2.96 0.33 (0.03) 1.04
Debt/Assets 3.35% 4.84% 25.20% 25.96% 26.72% 27.09% 21.24% 46.06% 57.39% 23.55%
Debt/Equity 0.05 0.07 0.47 0.51 0.51 0.52 0.44 3.84 4.85 0.47
Asset Turnover 1.14 1.09 0.76 0.62 0.58 0.52 0.71 1.07 0.99 0.89
Operating CF/Net income (1.03) (0.71) 0.57 0.79 0.71 0.79 0.51 0.55 0.71 0.74
Capex/Depreciation (3.20) (2.45) (1.48) (2.09) (2.02) (1.35) (0.54) (0.48) (1.21) (3.04)
Interest Coverage 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE (14.32%) (19.42%) (59.11%) (80.62%) (82.79%) (60.07%) (80.31%) (445.14%) (208.70%) (68.90%)
ROA (10.26%) (12.28%) (30.66%) (41.64%) (43.50%) (30.33%) (29.34%) (53.09%) (64.72%) (42.16%)
ROIC (27.03%) (45.18%) (111.70%) (199.67%) (422.60%) (10,224.90%) 0.00% 0.00% (285.12%) (710.26%)
Return on Tangible Assets (16.05%) (15.95%) (40.92%) (55.12%) (50.20%) (32.96%) (34.05%) (84.94%) (131.41%) (91.22%)
Average Days of Receivables 46.93 67.58 93.83 108.75 71.24 73.34 64.41 88.15 76.77 23.01
Research and Development Expense of Revenue 27.06% 23.82% 29.62% 38.58% 42.24% 25.58% 16.99% 19.93% 23.88% 19.70%
Selling, General and Administrative Expense of Revenue 51.05% 49.58% 57.11% 71.76% 81.70% 77.65% 68.20% 60.11% 74.09% 64.06%
Intangible Assets out of Total Assets 0.21 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Share Based Compensation of Revenue 15.37% 16.17% 17.72% 18.58% 18.42% 12.83% 9.47% 5.51% 5.44% 4.99%
Graham Net Nets 0.03 0.05 0.08 0.14 0.06 0.05 0.09 0.01 (0.02) 0.11
Graham Number 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield (0.67%) (0.97%) (6.12%) (14.47%) (5.54%) (2.82%) (5.37%) (15.97%) (27.24%) (15.56%)
Free Cash Flow Yield 0.35% 0.35% (4.02%) (12.65%) (4.45%) (2.51%) (2.92%) (9.22%) (21.33%) (15.85%)
Revenue per Share 16.87 13.61 9.41 8.33 6.91 4.83 4.35 4.45 3.93 4.12
Operating CF per Share 1.57 1.09 (2.15) (4.38) (3.70) (2.25) (0.91) (1.22) (1.83) (1.44)
Capex per Share (1.02) (0.62) (0.34) (0.48) (0.45) (0.24) (0.07) (0.07) (0.19) (0.45)
Free Cash Flow per Share 0.56 0.47 (2.49) (4.87) (4.15) (2.49) (0.98) (1.29) (2.02) (1.88)
Cash per Share 7.87 7.76 7.64 9.13 10.10 9.10 6.34 2.74 2.23 2.85
Shareholders Equity per Share 12.52 9.59 6.66 7.17 7.21 6.00 4.01 0.56 0.48 2.06
Interest Debt per Share 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share 12.52 9.59 6.66 7.17 7.21 6.00 4.01 0.56 0.48 2.06
Free Cash Flow 76.11 58.75 (286.15) (479.20) (376.27) (202.12) (68.41) (74.46) (107.69) (97.19)
Working Capital 1,055.71 1,031.78 951.28 901.32 874.18 663.61 343.29 126.54 75.06 77.70
Capital Expenditures (139.19) (76.92) (39.20) (47.70) (41.03) (19.60) (4.97) (3.88) (9.87) (23.14)
Net Current Asset Value 811.01 910.51 582.18 523.09 509.96 416.75 219.22 4.51 (8.57) 69.91
EV/EBIT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales 0.06 0.05 0.04 0.06 0.07 0.05 0.02 0.02 0.05 0.11
Net Profit Margin (9.03%) (11.22%) (40.16%) (66.79%) (75.42%) (58.76%) (41.29%) (49.74%) (65.65%) (47.21%)
Price to Operating Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets 0.18 0.19 0.24 0.25 0.31 0.44 0.39 0.33 0.27 0.24
Cash ROIC (0.90%) (1.18%) (17.84%) (26.65%) (21.11%) (14.62%) (10.28%) (30.22%) (47.66%) (35.06%)
Accounts Receivable Turnover 7.55 5.73 4.14 4.48 6.23 5.93 5.23 4.85 7.29 22.07
Accounts Payable Turnover 23.88 26.99 25.56 15.64 18.04 24.39 15.13 14.37 13.95 14.41
Inventory Turnover 14.36 15.76 15.49 14.64 13.57 12.56 13.48 14.68 18.12 18.69
Average Days of Payables 14.89 18.92 9.28 24.92 31.19 14.51 17.90 32.06 22.30 30.90
Days of Inventory on Hand 30.73 24.24 25.22 28.32 30.85 35.91 25.78 29.97 23.53 17.27
Average Receivables 305.35 296.23 261.34 183.23 100.32 65.96 57.79 53.16 28.74 9.63
Average Payables 34.04 24.96 23.07 29.18 17.65 8.35 11.60 11.56 10.00 9.41
Average Inventory 56.59 42.75 38.08 31.16 23.47 16.21 13.01 11.32 7.71 7.25
Average Assets 2,029.54 1,551.22 1,418.09 1,315.48 1,084.32 757.40 425.41 241.39 212.65 237.96
Average Common Equity 1,453.92 980.37 735.54 679.52 569.77 382.47 155.44 28.79 65.95 145.62

Fold the line items

Columns are period end dates